These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 6814549)

  • 1. Chronic hepatitis in patients with hemophilia A: histologic studies in patients with intermittently abnormal liver function tests.
    White GC; Zeitler KD; Lesesne HR; McMillan CW; Warren MS; Roberts HR; Blatt PM
    Blood; 1982 Dec; 60(6):1259-62. PubMed ID: 6814549
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence of type B and non-A, non-B hepatitis in hemophilia: relationship to chronic liver disease.
    Kim HC; Saidi P; Ackley AM; Bringelsen KA; Gocke DJ
    Gastroenterology; 1980 Dec; 79(6):1159-64. PubMed ID: 6777232
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chronic hepatitis in hemophilia.
    Hasiba U; Spero JA; Lewis JH
    Scand J Haematol Suppl; 1977; 30():27-32. PubMed ID: 267294
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A study of liver biopsies and liver disease among hemophiliacs.
    Aledort LM; Levine PH; Hilgartner M; Blatt P; Spero JA; Goldberg JD; Bianchi L; Desmet V; Scheuer P; Popper H
    Blood; 1985 Aug; 66(2):367-72. PubMed ID: 3926025
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Liver dysfunction in patients with hemophilia.
    Hilgartner MW; Giardina P
    Scand J Haematol Suppl; 1977; 30():6-10. PubMed ID: 267301
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chronic liver dysfunction in multitransfused hemophiliacs.
    Hasiba UW; Spero JA; Lewis JH
    Transfusion; 1977; 17(5):490-4. PubMed ID: 910267
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Liver dysfunction in Pennsylvania's multitransfused hemophiliacs.
    Hasiba U; Eyster ME; Gill FM; Kajani M; Lewis JH; Lusch CJ; Prager D; Rice SA; Shapiro SS
    Dig Dis Sci; 1980 Oct; 25(10):776-82. PubMed ID: 6775916
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatitis B virus, hepatitis A virus and persistently elevated aminotransferases in hemophiliacs.
    Gerety RJ; Eyster ME; Tabor E; Drucker JA; Lusch CJ; Prager D; Rice SA; Bowman HS
    J Med Virol; 1980; 6(2):111-8. PubMed ID: 6264019
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nonprogressive course of non-A, non-B chronic hepatitis in multitransfused hemophiliacs.
    Mannucci PM; Colombo M; Rizzetto M
    Blood; 1982 Sep; 60(3):655-8. PubMed ID: 6809075
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatitis, epidemiology and liver function in hemophiliacs in Sweden.
    Schulman S; Wiechel B
    Acta Med Scand; 1984; 215(3):249-56. PubMed ID: 6610281
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Percutaneous liver biopsy and chronic liver disease in haemophiliacs.
    Preston FE; Triger DR; Underwood JC; Bardhan G; Mitchell VE; Stewart RM; Blackburn EK
    Lancet; 1978 Sep; 2(8090):592-4. PubMed ID: 80524
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence of hepatitis B and C seromarkers and abnormal liver function tests among hemophiliacs in Guilan (northern province of Iran).
    Mansour-Ghanaei F; Fallah MS; Shafaghi A; Yousefi-Mashhoor M; Ramezani N; Farzaneh F; Nassiri R
    Med Sci Monit; 2002 Dec; 8(12):CR797-800. PubMed ID: 12503038
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Study of serological and biological markers in viral hepatitis. 157 hemophiliacs].
    Parquet-Gernez A; Boulanger-Fasquelle P; Maniez-Montreuil M; Goudemand M
    Rev Fr Transfus Immunohematol; 1981 Nov; 24(5):463-82. PubMed ID: 6798669
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibodies to hepatitic C virus and chronic liver disease among Finnish patients with haemophilia.
    Ebeling F; Rasi V; Naukkarinen R; Leikola J
    Ann Med; 1990 Dec; 22(6):393-6. PubMed ID: 1963789
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Commercial factor VIII associated hepatitis, 1974-75, in the United Kingdom: a retrospective survey.
    Craske J; Kirk P; Cohen B; Vandervelde EM
    J Hyg (Lond); 1978 Jun; 80(3):327-36. PubMed ID: 649945
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serial measurements of serum transaminases in renal transplant recipients with chronic hepatitis C: do they reflect disease severity?
    Besisik F; Sever MS; Dincer D; Cevikbas U; Türkoglu S; Cakaloglu Y; Kaymakoglu S; Okten A
    Clin Transplant; 2000 Dec; 14(6):529-32. PubMed ID: 11127304
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical safety of recombinant factor VIII. The rFactor VIII Clinical Trial Group.
    Brackman HH; Egli JE; Van Loo B
    Semin Hematol; 1991 Apr; 28(2 Suppl 1):37-42. PubMed ID: 1908125
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Side effects of substitution therapy--Newcastle 1976.
    Scand J Haematol Suppl; 1980; 35():55-64. PubMed ID: 6247760
    [No Abstract]   [Full Text] [Related]  

  • 19. Non-A non-B hepatitis after transfusion of factor VIII in infrequently treated patients.
    Fletcher ML; Trowell JM; Craske J; Pavier K; Rizza CR
    Br Med J (Clin Res Ed); 1983 Dec; 287(6407):1754-7. PubMed ID: 6416577
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A randomized controlled trial of recombinant interferon-alpha in chronic hepatitis C in hemophiliacs.
    Makris M; Preston FE; Triger DR; Underwood JC; Westlake L; Adelman MI
    Blood; 1991 Oct; 78(7):1672-7. PubMed ID: 1912556
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.